ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryGenevaXelios Pharmaresearch, A. Hügin
Xelios Pharmaresearch, A. Hügin Logo
Verified· 2 sourcesTrust ScoreNo score yet

Xelios Pharmaresearch, A. Hügin

Summary

About the company

The core activity of Xelios PharmaResearch is the development of new drugs for the treatment of specific skin diseases, in particular the discovery and development of treatments for Molluscum contagiosum, a viral skin infection. The activities include the identification of active ingredients, the acquisition of intellectual property rights and the conduct of clinical trials up to Phase II.

AI-generated
Trust & reputation

ranQ Trust Score of Xelios Pharmaresearch, A. Hügin

Trust Score

No score yet

x

A published score requires a data basis of at least 50% and data from at least two criteria groups other than identity. Missing evidence: Review quality, Review volume, Review recency, Media authority

Data basis 54%

LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
· As of October 2026
Xelios Pharmaresearch, A. Hügin has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Xelios Pharmaresearch, A. Hügin scores 78.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Xelios Pharmaresearch, A. Hügin scores 81.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).81.722%
Xelios Pharmaresearch, A. Hügin scores 0.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.0.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%

The data basis is 54%, below the threshold at which ranQ publishes a score. Evidence is missing for: Review quality, Review volume, Review recency, Media authority. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data. Full methodology

Knowledge

No knowledge articles yet

Once Xelios Pharmaresearch, A. Hügin has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Xelios Pharmaresearch, A. Hügin in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Xelios Pharmaresearch, A. Hügin by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Xelios Pharmaresearch, A. Hügin to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Avenue Eugène-Pittard 3
1206 Geneva

At a glance

Legal form
Sole proprietorship
UID
CHE-110.286.442
Founded
2003 · 23 years
Last commercial register change
November 11, 2003
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.67.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%

    • Similar companies

    CD
    Caisse de pensions Givaudan
    Vernier
    FG
    Fondation Givaudan
    Vernier
    GI
    Givaudan International SA
    Vernier
    GS
    Givaudan Suisse SA
    Vernier
    GS
    Givaudan SA
    Vernier
    GT
    Givaudan Treasury International SA
    Vernier
    MM
    MMV MEDICINES FOR MALARIA VENTURE
    Cointrin
    OP
    OM Pharma SA
    Meyrin